Sultan D. Y. Albakhit, Sajjad Ali, Sajood Qasim Ibrahim, K. R. Majeed, N. H. Faisal, Ali A. A. Al-Shawi, K. Hussein, O. Mohsein, W. A. Eltayb, Romisa Mamoun, Mohnad Abdalla
tlooto Summary
Overall, the current study proposed a strategy to combat COVID-19 using pharmaceuticals as prospective agents, which might also serve as a starting point for drug discovery.
Abstract
the other ligands. Among the demonstrated interactions with the protein, RMSD (root mean square deviation) values decreased due to the improved and more stable states. Conclusion: Overall, the current study proposed a strategy to combat COVID-19 using pharmaceuticals as prospective agents, which might also serve as a starting point for drug discovery. Additional studies on the target compounds are expected to yield substantial advances in the fight against COVID-19.
Citation format
ALBAKHIT, Sultan D. Y., et al. Molecular docking and dynamics of 2,5-pyrrolidinedione analogue using the SARS-CoV-2 main protease as target protein. Infection, Epidemiology and Microbiology, 2025.